MPM Oncology Impact Management as of June 30, 2021
Portfolio Holdings for MPM Oncology Impact Management
MPM Oncology Impact Management holds 14 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cullinan Management Common (CGEM) | 33.5 | $204M | 7.9M | 25.75 | |
| iTeos Therapeutics Common (ITOS) | 9.9 | $60M | 2.3M | 25.65 | |
| TCR2 Therapeutics Common | 9.1 | $55M | 3.4M | 16.41 | |
| Repare Therapeutics Common (RPTX) | 8.6 | $52M | 1.7M | 31.18 | |
| Harpoon Therapeutics Common | 7.3 | $44M | 3.2M | 13.87 | |
| Werewolf Therapeutics Common (HOWL) | 6.8 | $42M | 2.4M | 17.44 | |
| Oncorus Common | 5.4 | $33M | 2.4M | 13.80 | |
| MEI Pharma Common | 4.7 | $29M | 10M | 2.85 | |
| Turning Point Therapeutics Common | 3.5 | $21M | 269k | 78.02 | |
| Epizyme Common | 3.2 | $19M | 2.3M | 8.31 | |
| G1 Therapeutics Common | 2.9 | $18M | 813k | 21.94 | |
| Merus Common (MRUS) | 2.4 | $15M | 701k | 21.07 | |
| YmAbs Therapeutics Common (YMAB) | 1.9 | $11M | 337k | 33.80 | |
| ADC Therapeutics Common (ADCT) | 0.9 | $5.3M | 218k | 24.35 |
